Releases › ICD-10-CM FY2022

ICD-10-CM FY2022

Effective 2021-10-01 to 2022-03-31. 72,748 codes in the release.

191added

30revised

25removed

Codes added 191

Code	Description
A79.82	Anaplasmosis [A. phagocytophilum]
C56.3	Malignant neoplasm of bilateral ovaries
C79.63	Secondary malignant neoplasm of bilateral ovaries
C84.7A	Anaplastic large cell lymphoma, ALK-negative, breast
D55.21	Anemia due to pyruvate kinase deficiency
D55.29	Anemia due to other disorders of glycolytic enzymes
D75.83	Thrombocytosis
D75.838	Other thrombocytosis
D75.839	Thrombocytosis, unspecified
D89.44	Hereditary alpha tryptasemia
E75.244	Niemann-Pick disease type A/B
F32.A	Depression, unspecified
F78.A	Other genetic related intellectual disabilities
F78.A1	SYNGAP1-related intellectual disability
F78.A9	Other genetic related intellectual disability
G04.82	Acute flaccid myelitis
G44.86	Cervicogenic headache
G92.0	Immune effector cell-associated neurotoxicity syndrome
G92.00	Immune effector cell-associated neurotoxicity syndrome, grade unspecified
G92.01	Immune effector cell-associated neurotoxicity syndrome, grade 1
G92.02	Immune effector cell-associated neurotoxicity syndrome, grade 2
G92.03	Immune effector cell-associated neurotoxicity syndrome, grade 3
G92.04	Immune effector cell-associated neurotoxicity syndrome, grade 4
G92.05	Immune effector cell-associated neurotoxicity syndrome, grade 5
G92.8	Other toxic encephalopathy
G92.9	Unspecified toxic encephalopathy
I5A	Non-ischemic myocardial injury (non-traumatic)
K22.81	Esophageal polyp
K22.82	Esophagogastric junction polyp
K22.89	Other specified disease of esophagus
K31.A	Gastric intestinal metaplasia
K31.A0	Gastric intestinal metaplasia, unspecified
K31.A1	Gastric intestinal metaplasia without dysplasia
K31.A11	Gastric intestinal metaplasia without dysplasia, involving the antrum
K31.A12	Gastric intestinal metaplasia without dysplasia, involving the body (corpus)
K31.A13	Gastric intestinal metaplasia without dysplasia, involving the fundus
K31.A14	Gastric intestinal metaplasia without dysplasia, involving the cardia
K31.A15	Gastric intestinal metaplasia without dysplasia, involving multiple sites
K31.A19	Gastric intestinal metaplasia without dysplasia, unspecified site
K31.A2	Gastric intestinal metaplasia with dysplasia
K31.A21	Gastric intestinal metaplasia with low grade dysplasia
K31.A22	Gastric intestinal metaplasia with high grade dysplasia
K31.A29	Gastric intestinal metaplasia with dysplasia, unspecified
L24.A	Irritant contact dermatitis due to friction or contact with body fluids
L24.A0	Irritant contact dermatitis due to friction or contact with body fluids, unspecified
L24.A1	Irritant contact dermatitis due to saliva
L24.A2	Irritant contact dermatitis due to fecal, urinary or dual incontinence
L24.A9	Irritant contact dermatitis due friction or contact with other specified body fluids
L24.B	Irritant contact dermatitis related to stoma or fistula
L24.B0	Irritant contact dermatitis related to unspecified stoma or fistula
L24.B1	Irritant contact dermatitis related to digestive stoma or fistula
L24.B2	Irritant contact dermatitis related to respiratory stoma or fistula
L24.B3	Irritant contact dermatitis related to fecal or urinary stoma or fistula
M31.10	Thrombotic microangiopathy, unspecified
M31.11	Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]
M31.19	Other thrombotic microangiopathy
M35.05	Sjogren syndrome with inflammatory arthritis
M35.06	Sjogren syndrome with peripheral nervous system involvement
M35.07	Sjogren syndrome with central nervous system involvement
M35.08	Sjogren syndrome with gastrointestinal involvement
M35.0A	Sjogren syndrome with glomerular disease
M35.0B	Sjogren syndrome with vasculitis
M35.0C	Sjogren syndrome with dental involvement
M45.A	Non-radiographic axial spondyloarthritis
M45.A0	Non-radiographic axial spondyloarthritis of unspecified sites in spine
M45.A1	Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region
M45.A2	Non-radiographic axial spondyloarthritis of cervical region
M45.A3	Non-radiographic axial spondyloarthritis of cervicothoracic region
M45.A4	Non-radiographic axial spondyloarthritis of thoracic region
M45.A5	Non-radiographic axial spondyloarthritis of thoracolumbar region
M45.A6	Non-radiographic axial spondyloarthritis of lumbar region
M45.A7	Non-radiographic axial spondyloarthritis of lumbosacral region
M45.A8	Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region
M45.AB	Non-radiographic axial spondyloarthritis of multiple sites in spine
M54.50	Low back pain, unspecified
M54.51	Vertebrogenic low back pain
M54.59	Other low back pain
P00.82	Newborn affected by (positive) maternal group B streptococcus (GBS) colonization
P09.1	Abnormal findings on neonatal screening for inborn errors of metabolism
P09.2	Abnormal findings on neonatal screening for congenital endocrine disease
P09.3	Abnormal findings on neonatal screening for congenital hematologic disorders
P09.4	Abnormal findings on neonatal screening for cystic fibrosis
P09.5	Abnormal findings on neonatal screening for critical congenital heart disease
P09.6	Abnormal findings on neonatal screening for neonatal hearing loss
P09.8	Other abnormal findings on neonatal screening
P09.9	Abnormal findings on neonatal screening, unspecified
R05.1	Acute cough
R05.2	Subacute cough
R05.3	Chronic cough
R05.4	Cough syncope
R05.8	Other specified cough
R05.9	Cough, unspecified
R35.81	Nocturnal polyuria
R35.89	Other polyuria
R45.88	Nonsuicidal self-harm
R63.30	Feeding difficulties, unspecified
R63.31	Pediatric feeding disorder, acute
R63.32	Pediatric feeding disorder, chronic
R63.39	Other feeding difficulties
R79.83	Abnormal findings of blood amino-acid level
S06.A	Traumatic brain compression and herniation
S06.A0	Traumatic brain compression without herniation
S06.A0XA	Traumatic brain compression without herniation, initial encounter
S06.A0XD	Traumatic brain compression without herniation, subsequent encounter
S06.A0XS	Traumatic brain compression without herniation, sequela
S06.A1	Traumatic brain compression with herniation
S06.A1XA	Traumatic brain compression with herniation, initial encounter
S06.A1XD	Traumatic brain compression with herniation, subsequent encounter
S06.A1XS	Traumatic brain compression with herniation, sequela
T40.71	Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
T40.711	Poisoning by cannabis, accidental (unintentional)
T40.711A	Poisoning by cannabis, accidental (unintentional), initial encounter
T40.711D	Poisoning by cannabis, accidental (unintentional), subsequent encounter
T40.711S	Poisoning by cannabis, accidental (unintentional), sequela
T40.712	Poisoning by cannabis, intentional self-harm
T40.712A	Poisoning by cannabis, intentional self-harm, initial encounter
T40.712D	Poisoning by cannabis, intentional self-harm, subsequent encounter
T40.712S	Poisoning by cannabis, intentional self-harm, sequela
T40.713	Poisoning by cannabis, assault
T40.713A	Poisoning by cannabis, assault, initial encounter
T40.713D	Poisoning by cannabis, assault, subsequent encounter
T40.713S	Poisoning by cannabis, assault, sequela
T40.714	Poisoning by cannabis, undetermined
T40.714A	Poisoning by cannabis, undetermined, initial encounter
T40.714D	Poisoning by cannabis, undetermined, subsequent encounter
T40.714S	Poisoning by cannabis, undetermined, sequela
T40.715	Adverse effect of cannabis
T40.715A	Adverse effect of cannabis, initial encounter
T40.715D	Adverse effect of cannabis, subsequent encounter
T40.715S	Adverse effect of cannabis, sequela
T40.716	Underdosing of cannabis
T40.716A	Underdosing of cannabis, initial encounter
T40.716D	Underdosing of cannabis, subsequent encounter
T40.716S	Underdosing of cannabis, sequela
T40.72	Poisoning by, adverse effect of and underdosing of synthetic cannabinoids
T40.721	Poisoning by synthetic cannabinoids, accidental (unintentional)
T40.721A	Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
T40.721D	Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
T40.721S	Poisoning by synthetic cannabinoids, accidental (unintentional), sequela
T40.722	Poisoning by synthetic cannabinoids, intentional self-harm
T40.722A	Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter
T40.722D	Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
T40.722S	Poisoning by synthetic cannabinoids, intentional self-harm, sequela
T40.723	Poisoning by synthetic cannabinoids, assault
T40.723A	Poisoning by synthetic cannabinoids, assault, initial encounter
T40.723D	Poisoning by synthetic cannabinoids, assault, subsequent encounter
T40.723S	Poisoning by synthetic cannabinoids, assault, sequela
T40.724	Poisoning by synthetic cannabinoids, undetermined
T40.724A	Poisoning by synthetic cannabinoids, undetermined, initial encounter
T40.724D	Poisoning by synthetic cannabinoids, undetermined, subsequent encounter
T40.724S	Poisoning by synthetic cannabinoids, undetermined, sequela
T40.725	Adverse effect of synthetic cannabinoids
T40.725A	Adverse effect of synthetic cannabinoids, initial encounter
T40.725D	Adverse effect of synthetic cannabinoids, subsequent encounter
T40.725S	Adverse effect of synthetic cannabinoids, sequela
T40.726	Underdosing of synthetic cannabinoids
T40.726A	Underdosing of synthetic cannabinoids, initial encounter
T40.726D	Underdosing of synthetic cannabinoids, subsequent encounter
T40.726S	Underdosing of synthetic cannabinoids, sequela
T80.82	Complication of immune effector cellular therapy
T80.82XA	Complication of immune effector cellular therapy, initial encounter
T80.82XD	Complication of immune effector cellular therapy, subsequent encounter
T80.82XS	Complication of immune effector cellular therapy, sequela
U09	Post COVID-19 condition
U09.9	Post COVID-19 condition, unspecified
Y35.899	Legal intervention involving other specified means, unspecified person injured
Y35.899A	Legal intervention involving other specified means, unspecified person injured, initial encounter
Y35.899D	Legal intervention involving other specified means, unspecified person injured, subsequent encounter
Y35.899S	Legal intervention involving other specified means, unspecified person injured, sequela
Z55.5	Less than a high school diploma
Z58	Problems related to physical environment
Z58.6	Inadequate drinking-water supply
Z59.00	Homelessness unspecified
Z59.01	Sheltered homelessness
Z59.02	Unsheltered homelessness
Z59.41	Food insecurity
Z59.48	Other specified lack of adequate food
Z59.81	Housing instability, housed
Z59.811	Housing instability, housed, with risk of homelessness
Z59.812	Housing instability, housed, homelessness in past 12 months
Z59.819	Housing instability, housed unspecified
Z59.89	Other problems related to housing and economic circumstances
Z71.85	Encounter for immunization safety counseling
Z91.014	Allergy to mammalian meats
Z91.51	Personal history of suicidal behavior
Z91.52	Personal history of nonsuicidal self-harm
Z92.85	Personal history of cellular therapy
Z92.850	Personal history of Chimeric Antigen Receptor T-cell therapy
Z92.858	Personal history of other cellular therapy
Z92.859	Personal history of cellular therapy, unspecified
Z92.86	Personal history of gene therapy

Descriptions revised 30

Code	Was, and is now
F32	~~Major depressive disorder, single episode~~ Depressive episode
G71.20	~~Congenital myopathy, unspecifed~~ Congenital myopathy, unspecified
M35.0	~~Sicca syndrome [Sjogren]~~ Sjogren syndrome
M35.00	~~Sicca syndrome, unspecified~~ Sjogren syndrome, unspecified
M35.01	~~Sicca syndrome with keratoconjunctivitis~~ Sjogren syndrome with keratoconjunctivitis
M35.02	~~Sicca syndrome with lung involvement~~ Sjogren syndrome with lung involvement
M35.03	~~Sicca syndrome with myopathy~~ Sjogren syndrome with myopathy
M35.04	~~Sicca syndrome with tubulo-interstitial nephropathy~~ Sjogren syndrome with tubulo-interstitial nephropathy
M35.09	~~Sicca syndrome with other organ involvement~~ Sjogren syndrome with other organ involvement
T63.61	~~Toxic effect of contact with Portugese Man-o-war~~ Toxic effect of contact with Portuguese Man-o-war
T63.611	~~Toxic effect of contact with Portugese Man-o-war, accidental (unintentional)~~ Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional)
T63.611A	~~Toxic effect of contact with Portugese Man-o-war, accidental (unintentional), initial encounter~~ Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), initial encounter
T63.611D	~~Toxic effect of contact with Portugese Man-o-war, accidental (unintentional), subsequent encounter~~ Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), subsequent encounter
T63.611S	~~Toxic effect of contact with Portugese Man-o-war, accidental (unintentional), sequela~~ Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), sequela
T63.612	~~Toxic effect of contact with Portugese Man-o-war, intentional self-harm~~ Toxic effect of contact with Portuguese Man-o-war, intentional self-harm
T63.612A	~~Toxic effect of contact with Portugese Man-o-war, intentional self-harm, initial encounter~~ Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, initial encounter
T63.612D	~~Toxic effect of contact with Portugese Man-o-war, intentional self-harm, subsequent encounter~~ Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, subsequent encounter
T63.612S	~~Toxic effect of contact with Portugese Man-o-war, intentional self-harm, sequela~~ Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, sequela
T63.613	~~Toxic effect of contact with Portugese Man-o-war, assault~~ Toxic effect of contact with Portuguese Man-o-war, assault
T63.613A	~~Toxic effect of contact with Portugese Man-o-war, assault, initial encounter~~ Toxic effect of contact with Portuguese Man-o-war, assault, initial encounter
T63.613D	~~Toxic effect of contact with Portugese Man-o-war, assault, subsequent encounter~~ Toxic effect of contact with Portuguese Man-o-war, assault, subsequent encounter
T63.613S	~~Toxic effect of contact with Portugese Man-o-war, assault, sequela~~ Toxic effect of contact with Portuguese Man-o-war, assault, sequela
T63.614	~~Toxic effect of contact with Portugese Man-o-war, undetermined~~ Toxic effect of contact with Portuguese Man-o-war, undetermined
T63.614A	~~Toxic effect of contact with Portugese Man-o-war, undetermined, initial encounter~~ Toxic effect of contact with Portuguese Man-o-war, undetermined, initial encounter
T63.614D	~~Toxic effect of contact with Portugese Man-o-war, undetermined, subsequent encounter~~ Toxic effect of contact with Portuguese Man-o-war, undetermined, subsequent encounter
T63.614S	~~Toxic effect of contact with Portugese Man-o-war, undetermined, sequela~~ Toxic effect of contact with Portuguese Man-o-war, undetermined, sequela
Z59.4	~~Lack of adequate food and safe drinking water~~ Lack of adequate food
Z68.30	~~Body mass index [BMI]30.0-30.9, adult~~ Body mass index [BMI] 30.0-30.9, adult
Z68.41	~~Body mass index [BMI]40.0-44.9, adult~~ Body mass index [BMI] 40.0-44.9, adult
Z92.25	~~Personal history of immunosupression therapy~~ Personal history of immunosuppression therapy

Codes removed 25

Code	Description
T40.7X	Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
T40.7X1	Poisoning by cannabis (derivatives), accidental (unintentional)
T40.7X1A	Poisoning by cannabis (derivatives), accidental (unintentional), initial encounter
T40.7X1D	Poisoning by cannabis (derivatives), accidental (unintentional), subsequent encounter
T40.7X1S	Poisoning by cannabis (derivatives), accidental (unintentional), sequela
T40.7X2	Poisoning by cannabis (derivatives), intentional self-harm
T40.7X2A	Poisoning by cannabis (derivatives), intentional self-harm, initial encounter
T40.7X2D	Poisoning by cannabis (derivatives), intentional self-harm, subsequent encounter
T40.7X2S	Poisoning by cannabis (derivatives), intentional self-harm, sequela
T40.7X3	Poisoning by cannabis (derivatives), assault
T40.7X3A	Poisoning by cannabis (derivatives), assault, initial encounter
T40.7X3D	Poisoning by cannabis (derivatives), assault, subsequent encounter
T40.7X3S	Poisoning by cannabis (derivatives), assault, sequela
T40.7X4	Poisoning by cannabis (derivatives), undetermined
T40.7X4A	Poisoning by cannabis (derivatives), undetermined, initial encounter
T40.7X4D	Poisoning by cannabis (derivatives), undetermined, subsequent encounter
T40.7X4S	Poisoning by cannabis (derivatives), undetermined, sequela
T40.7X5	Adverse effect of cannabis (derivatives)
T40.7X5A	Adverse effect of cannabis (derivatives), initial encounter
T40.7X5D	Adverse effect of cannabis (derivatives), subsequent encounter
T40.7X5S	Adverse effect of cannabis (derivatives), sequela
T40.7X6	Underdosing of cannabis (derivatives)
T40.7X6A	Underdosing of cannabis (derivatives), initial encounter
T40.7X6D	Underdosing of cannabis (derivatives), subsequent encounter
T40.7X6S	Underdosing of cannabis (derivatives), sequela

Stopped being billable 15

Code	Description
D55.2	Anemia due to disorders of glycolytic enzymes
F78	Other intellectual disabilities
G92	Toxic encephalopathy
K22.8	Other specified diseases of esophagus
M31.1	Thrombotic microangiopathy
M54.5	Low back pain
P09	Abnormal findings on neonatal screening
R05	Cough
R35.8	Other polyuria
R63.3	Feeding difficulties
Z28.3	Underimmunization status
Z59.0	Homelessness
Z59.4	Lack of adequate food
Z59.8	Other problems related to housing and economic circumstances
Z91.5	Personal history of self-harm